Medistim ASA (OSL:MEDI)

Market Cap	3.91B +13.7%
Revenue (ttm)	699.77M +25.8%
Net Income	159.21M +53.3%
EPS	8.71 +53.6%
Shares Out	18.28M
PE Ratio	24.57
Forward PE	25.25
Dividend	8.00 (3.74%)
Ex-Dividend Date	May 7, 2026

Volume	20,676
Average Volume	29,660
Open	214.00
Previous Close	211.00
Day's Range	213.00 - 219.00
52-Week Range	153.00 - 292.00
Beta	1.02
RSI	52.23
Earnings Date	Apr 14, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 25.82% compared to the previous year's 556.16 million. Earnings were 159.21 million, an increase of 53.33%.